The companies aim to create customized AI models and agents that Novo Nordisk can use for early research and clinical development
Integrated facility to deliver end-to-end, customized workflows across life sciences, diagnostics, and applied markets
Akums and TNAU will collaborate to strengthen research through shared expertise and innovative agricultural solutions, to foster innovation in formulation development
Being a premium partner for pharmaceutical companies by contributing to safety and productivity of pharmaceutical manufacture
The Emcure Research Centre (ERC) will drive research across multiple dosage forms, including OSD, injectables, novel drug delivery systems (NDDS), inhalers and topical and transdermal formulations
This product is an oral SYK inhibitor and suppresses platelet destruction by macrophages and platelet depletion
The centre features a cutting-edge climatic chamber for stability testing and spectrophotometry to ensure that products meet the most stringent manufacturing and testing standards
Revolutionary technology will further boost OneSource’s scientific services offerings
Global TB incidence saw a reduction of 8.7% while in India we were able to demonstrate a reduction of 16%, almost double the pace
New effective carrier systems for drug delivery in different dosage applications including oral, topical & parenteral
Subscribe To Our Newsletter & Stay Updated
